[HTML][HTML] The Role of Pentraxin 3 in Gastrointestinal Cancers

M Zajkowska, B Mroczko - Cancers, 2023 - mdpi.com
Simple Summary Gastrointestinal (GI) cancers are all malignant lesions affecting the
esophagus, stomach, liver and intrahepatic bile ducts, gallbladder, pancreas, and small and …

Human Papillomavirus Genotype Distribution Patterns in Zimbabwe: Is the Bivalent Vaccine Sufficient?

T Marembo, MB Fitzpatrick, RS Dube Mandishora - Intervirology, 2024 - karger.com
Human papillomavirus genotype distribution patterns in Zimbabwe; is the bivalent vaccine
sufficient? Page 1 1 Intervirology , DOI: 10.1159/000531347 Received: May 24, 2020 Accepted …

Trends in epidemiology and primary treatment of anal squamous cell carcinoma in the Netherlands (1990–2021)

VKY Ho, CL Deijen, B Hemmes… - … Journal of Cancer, 2024 - Wiley Online Library
A rapid increase in the incidence of anal squamous cell carcinoma (SCC) was reported in
several countries over the past decades. This study assessed trends in epidemiology and …

Prognostic and predictive role of YKL-40 in anal squamous cell carcinoma: a serological and tissue-based analysis in a multicentric cohort

A Gambella, R Senetta, EC Falco, AA Ricci… - Frontiers in …, 2024 - frontiersin.org
Introduction Anal squamous cell carcinoma (ASC) is a rare gastrointestinal malignancy
showing an increased incidence over the past decades. YKL-40 is an immune modulator …

Assessing Circulating Tumour DNA (ctDNA) as a Biomarker for Anal Cancer Management: A Systematic Review

HC Temperley, T Fannon, NJ O'Sullivan… - International Journal of …, 2024 - mdpi.com
This systematic review investigates the potential of circulating tumour DNA (ctDNA) as a
predictive biomarker in the management and prognosis of squamous cell carcinoma of the …

Prognostic value of PD-L1 expression in patients with anal cancer: a meta-analysis

S Gong, J Song - Biomarkers in Medicine, 2024 - Taylor & Francis
Background: The present meta-analysis was performed to evaluate the prognostic and
clinicopathological significance of PD-L1 in anal cancer (AC). Methods: Hazard ratios (HRs) …

Evaluation of dual p16/Ki‐67 immunostaining on anal cytology specimens

MC Smithgall, WS Towne, AA Gonzalez… - Diagnostic …, 2024 - Wiley Online Library
Introduction Dual immunostaining for p16/Ki67 is FDA‐approved for use on liquid‐based
cervical cytology specimens; however, the utility of dual staining in anal cytology especially …

Anal cancer risk and HPV infection knowledge and awareness among Hispanic persons living with HIV in Puerto Rico.

J Hernandez-Marrero, JM Ramos-Cartagena… - Research …, 2024 - ncbi.nlm.nih.gov
Background: Persons living with HIV (PLWH) have a higher risk of persistent infection with
human papillomavirus (HPV) and anal cancer. We evaluated knowledge and awareness of …

[HTML][HTML] Translation and validation of the Hindi, Marathi, and Bangla versions of the European Organization for Research and Treatment of Cancer Quality-of-Life …

R Krishnatry, R Krishnamurthy, P Pawar… - Cancer Research …, 2024 - journals.lww.com
Background: The European Organization for the Research and Treatment of Cancer
(EORTC) has developed a commonly used validated questionnaire specific to anal cancer …

Rapidly growing primary anal canal lymphoma: a case report and literature review

YK Chung, SB Park - Gastroenterology Report, 2023 - academic.oup.com
Anal cancer is a rare cancer accounting for $2% of all gastrointestinal tract malignancies [1].
Among anal cancers, squamous cell cancer (SCC) is the most common and lymphoma is …